loader image
Monday, December 22, 2025
84.7 F
McAllen
- Advertisement -

7 Best Multivitamins For Men Over 50

Some males ages 50 years and over may benefit from taking a multivitamin to support their health and quality of life as they get older. The best product will depend on individual age, medications, and health status.

Translate to Spanish or other 102 languages!

The best product will depend on individual age, medications, and health status. Image for illustration purposes
The best product will depend on individual age, medications, and health status. Image for illustration purposes

Medical News Today

- Advertisement -

A quick look at the best multivitamins for men

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/best-multivitamin-for-men-over-50?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-03-01&apid=&rvid=079da5ada992cf89183b8daba474d846b774c1cab825a30c1edc4e1bd42a6b12#_noHeaderPrefixedContent

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×